Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cixutumumab and Temsirolimus in Treating Patients With Locally Advanced or Metastatic Cancer

This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: May 14, 2008
Last updated: November 3, 2015
Last verified: November 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2015
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):